Air Liquide Strengthens Its Home Healthcare Offer With a Major Acquisition in Poland
07 Oktober 2021 - 8:45AM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) is continuing to develop its home
healthcare business in Europe with the acquisition of Betamed S.A.,
a major home healthcare provider in Poland. Betamed specialises in
the care of patients with severe pathologies, either at home or in
its specialised clinic in Chorzów in Silesia. This acquisition
enables the Group to strengthen its presence in Poland and to
expand its range of services to support patients suffering from
complex forms of chronic diseases.
Founded in 2001 and headed by Beata Drzazga, Betamed S.A. is the
Polish leader in home healthcare for patients suffering from
severe pathologies, such as respiratory diseases, stroke, heart
disease, neuromuscular diseases or paraplegia. The company supports
5,000 patients, and also runs a specialised clinic
with over 100 beds for dependent patients, both adults and
children, who require mechanical ventilation. In 2020, Betamed S.A.
generated revenue of nearly 25 million euros.
Since 2012, Air Liquide has made several acquisitions in home
healthcare in Poland, and is now a recognised player in mechanical
ventilation at home, in the country. The acquisition of Betamed
S.A. marks a new stage in the development of its home healthcare
business in Poland, as it enables the Group to offer its
patients a broader, more diversified and complementary range of
services across the entire care pathway, through an extended
geographical presence. In addition to the expertise of the founder
of Betamed S.A., Beata Drzazga, Air Liquide Healthcare will rely on
the existing teams to further develop its business.
Diana Schillag, member of the Air Liquide Group’s
Executive Committee supervising the Healthcare business line,
declared: “We are pleased to welcome to Air Liquide Healthcare
the teams of Betamed S.A., recognised for their expertise in the
monitoring and care of patients with severe pathologies. This
operation will enable the Group to strengthen its offer and its
presence in home healthcare in Poland, in line with the strategy
that the Group is deploying in the rest of Europe. As a major
player in home healthcare, Air Liquide’s ambition is to best meet
the needs of patients and healthcare professionals.”
Air Liquide’s
Home Healthcare business
Air Liquide, the leading European
player in home healthcare, provides prescription care for
patients suffering from chronic diseases such as COPD (Chronic
Obstructive Pulmonary Disease), sleep apnoea, Parkinson’s disease
and diabetes. Alongside hospital care, this business is developing
in the patient’s home, since it enables better quality of life and
a reduction in treatment costs. Home healthcare business represents
50% of Air Liquide’s 2020 Healthcare business revenue.
A world leader in gases, technologies and
services for Industry and Health, Air Liquide is present in 78
countries with approximately 64,500 employees and serves more than
3.8 million customers and patients. Oxygen, nitrogen and hydrogen
are essential small molecules for life, matter and energy. They
embody Air Liquide’s scientific territory and have been at the core
of the company’s activities since its creation in 1902.
Air Liquide’s ambition is to be a leader
in its industry, deliver long term performance and contribute to
sustainability - with a strong commitment to climate change and
energy transition at the heart of its strategy. The company’s
customer-centric transformation strategy aims at profitable,
regular and responsible growth over the long term. It relies on
operational excellence, selective investments, open innovation and
a network organization implemented by the Group worldwide. Through
the commitment and inventiveness of its people, Air Liquide
leverages energy and environment transition, changes in healthcare
and digitization, and delivers greater value to all its
stakeholders.
Air Liquide’s revenue amounted to more
than 20 billion euros in 2020. Air Liquide is listed on the
Euronext Paris stock exchange (compartment A) and belongs to the
CAC 40, EURO STOXX 50 and FTSE4Good indexes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211006006071/en/
Corporate Communications media@airliquide.com
Investor Relations IRTeam@airliquide.com
Air Liquide (EU:AI)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Air Liquide (EU:AI)
Historical Stock Chart
Von Apr 2023 bis Apr 2024